XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating activities:    
Net loss $ (34,358) $ (59,949)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Stock-based compensation expense 31,076 36,129
Depreciation and amortization 8,022 9,194
Amortization of right-of-use assets 1,792 2,300
Lease and asset impairment charges 114 2,454
Other (575) 444
Changes in operating assets and liabilities:    
Accounts receivable 35,325 23,516
Inventory 8,058 (9,937)
Prepaid expenses and other current assets (5,530) (2,029)
Other noncurrent assets 2,314 216
Accounts payable (2,547) 4,583
Accrued compensation and other related benefits (11,745) (9,380)
Deferred revenue 347 2,120
Accrued expenses and other current liabilities 4,329 (12,674)
Operating lease liability (2,631) (2,961)
Other noncurrent liabilities 360 249
Net cash provided by (used in) operating activities 34,351 (15,725)
Investing activities:    
Purchases of property and equipment (1,893) (2,910)
Proceeds from sales of marketable securities 0 568
Proceeds from maturities of marketable securities 0 12,974
Net cash provided by (used in) investing activities (1,893) 10,632
Financing activities:    
Issuance of common stock from exercise of stock options and employee stock purchase plan purchases 422 1,638
Net cash provided by financing activities 422 1,638
Effect of exchange rates changes on cash, cash equivalents 114 (48)
Net increase (decrease) in cash and cash equivalents 32,994 (3,503)
Cash, cash equivalents, and restricted cash at beginning of period 344,067 359,284
Cash, cash equivalents, and restricted cash at end of period 377,061 355,781
Supplemental disclosures of cash flow information:    
Cash paid for taxes 462 961
Noncash investing and financing activities:    
Purchases of property and equipment included in accounts payable and accrued expenses and other current liabilities $ 398 $ 1,899